Antifungal susceptibility testing (AFST)
Diagnostic Testtesting the fungal susceptibility to different drugs
NCT Number: NCT06729216
The aim of the study is to compare the efficiency of broth microdilution versus disk diffusion method for antifungal drug susceptibility testing of the most used drugs in dermatophytosis treatment.
Trial opening soon.
Get NotifiedAll sexes
Observational
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
testing the fungal susceptibility to different drugs
Time frame: 3 months
Measure the area of inhibition zone of the drugs to the fungus on the culture
Cairo University
Other
Species Identification and Antifungal Susceptibility Testing of Dermatophytes Isolated From Patients Attending Dermatology Outpatient Clinic at Kasr Alainy Hospitals
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06680544
Bacterial Infections and Mycoses, Dermatomycoses
Rahim Yar Khan, Punjab Province, Pakistan
View Trial DetailsNCT04880980
Bacterial Infections and Mycoses, Dermatomycoses
Rawalpindi, Punjab Province, Pakistan
View Trial DetailsNCT00722189
Bacterial Infections and Mycoses, Dermatomycoses
Saint Petersburg, Russia
View Trial DetailsNCT03320486
Bacterial Infections and Mycoses, Dermatomycoses
Campinas, São Paulo, Brazil
View Trial Details